100 Most Influential People in Healthcare
President and CEO,
Brandicourt joined the large biopharma company in 2015 after serving as CEO of Bayer Healthcare. Prior to that, Brandicourt, spent 13 years at Pfizer. Sanofi sales took a hit this year due to the loss of patent protection on diabetes drugs. Nonetheless, Brandicourt in an earnings call said he expects the company to enter a "new growth phase" in the second half of the year. The company is eyeing growth in new areas, including treatment for cancers and eczema.